## **Core Concept**
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired, life-threatening disease of the blood characterized by the destruction of red blood cells (hemolysis), bone marrow failure, and the presence of blood clots (thrombosis). It is associated with a defect in the **complement** regulatory proteins on the surface of blood cells.

## **Why the Correct Answer is Right**
The correct answer, **GPI (Glycosylphosphatidylinositol) anchor**, is related to the pathophysiology of PNH. PNH is caused by a mutation in the **PIGA (phosphatidylinositol glycan class A)** gene, which is necessary for the synthesis of the GPI anchor. The GPI anchor is crucial for attaching many proteins to the cell membrane, including **CD55 (decay-accelerating factor)** and **CD59 (membrane inhibitor of reactive lysis)**, which regulate the complement system and protect red blood cells from complement-mediated lysis. Without these protective proteins, red blood cells are more susceptible to destruction by the complement system.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While complement and its regulators are involved in PNH, stating "complement" alone is too broad and does not specify the mechanism of the disease.
- **Option B:** This option is incorrect because while complement regulatory proteins are involved, the specific deficiency in PNH is more directly related to the GPI anchor deficiency, which leads to the lack of these proteins on the cell surface.
- **Option D:** This option is incorrect because it does not accurately represent the primary defect in PNH.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that PNH patients are at increased risk of thrombosis, and the disease can present with **nocturnal hemoglobinuria**, hemolytic anemia, and bone marrow failure. The diagnosis often involves flow cytometry to detect the deficiency of GPI-anchored proteins.

## **Correct Answer:** . GPI anchor